The rates and severity of these AEs vary by agent, formulation, and dosing schedule
59 In MASLD patients with inadequate glycemic control on metformin, sitagliptin (a DPP-4 inhibitor) and liraglutide 1.8 mg daily showed no significant differences in improving LFC assessed by MRI-PDFF, visceral adipose tissue, and weight reduction
In these studies, participants taking Mounjaro experienced average weight losses of 15% to over 20% of their body weight at higher doses, with the majority of this weight loss coming from fat
At Cape Fear Physical Medicine and Rehab, we are committed to helping patients achieve optimal health and quality of life, especially when managing chronic conditions affecting mobility and well-being
S.FrancisJ
Furthermore, GLP-1 sends signals to the brain to promote feelings of fullness and satisfaction, which naturally can aid in weight loss